<ARTICLE>5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb For Year Ended 12/31/98 </LEGEND> <MULTIPLIER>1000000 <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> Dec-31-1998 <PERIOD-END> Dec-31-1998<F1> <CASH> 2244 <SECURITIES> 285 <RECEIVABLES> 3337 <ALLOWANCES> 147 <INVENTORY> 1873 <CURRENT-ASSETS> 8782 <PP&E> 7508 <DEPRECIATION> 3079 <TOTAL-ASSETS> 16272 <CURRENT-LIABILITIES> 5791 <BONDS> 1364 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 219 <OTHER-SE> 7357 <TOTAL-LIABILITY-AND-EQUITY> 16272 <SALES> 18284 <TOTAL-REVENUES> 18284 <CGS> 4856 <TOTAL-COSTS> 4856 <OTHER-EXPENSES> 3889 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 154 <INCOME-PRETAX> 4268 <INCOME-TAX> 1127 <INCOME-CONTINUING> 3141 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 3141 <EPS-PRIMARY> 1.58 <EPS-DILUTED> 1.55 <FN> <F1> Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. E-7-1